Mason Morfit

From Wikipedia, the free encyclopedia
Jump to: navigation, search

G. Mason Morfit is CFA and president of ValueAct Capital. He was appointed on Board of Directors of Microsoft in March-2014.[1][2]

Education[edit]

Morfit has B.A. from Princeton University and he is a CFA charter holder. [clarification needed]

Career[edit]

Morfit joined the ValueAct Capital in January 2001. Prior to that he worked in equity research for Credit Suisse First Boston. He is a director of Valeant Pharmaceuticals International and a former director of Advanced Medical Optics, Inc., C.R. Bard, Inc., Immucor, Inc., MSD Performance, Inc. and Solexa, Inc.[3]

References[edit]

  1. ^ Profile, valuewalk.com; accessed September 22, 2014.
  2. ^ Profile, softpedia.com; accessed September 22, 2014.
  3. ^ Profile, valueact.com; accessed September 22, 2014.